<SEC-DOCUMENT>0001104659-20-111767.txt : 20201123
<SEC-HEADER>0001104659-20-111767.hdr.sgml : 20201123
<ACCEPTANCE-DATETIME>20201002171618
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-20-111767
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20201002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GILEAD SCIENCES INC
		CENTRAL INDEX KEY:			0000882095
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943047598
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6505743000

	MAIL ADDRESS:	
		STREET 1:		333 LAKESIDE DR
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="65%" valign="top" style="padding:0in 0in 0in 0in;width:65.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="20%" valign="top" style="padding:0in 0in 0in 0in;width:20.0%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">New York</font></b><b><br>    </b><b>Northern California</b><b><br>    </b><b>Washington DC<br>   S&#227;o Paulo<br>   London</b></p>    </td>
<td width="14%" valign="top" style="padding:0in 0in 0in 0in;width:14.16%;">
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Paris</font></b><b><br>    </b><b>Madrid</b><b><br>    </b><b>Hong Kong</b><b><br>    </b><b>Beijing</b><b><br>    </b><b>Tokyo</b></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="155" height="30" src="g3081010bci001.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Marc O. Williams,&nbsp;Esq.</font></b></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="72%" valign="top" style="padding:0in 0in 0in 0in;width:72.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="25%" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Davis Polk&nbsp;&amp; Wardwell LLP<br>   450 Lexington Avenue<br>   New York, NY 10017</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="72%" valign="top" style="padding:0in 0in 0in 0in;width:72.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">212 450 6145 tel<br>   212 701 5843 fax<br>   marc.williams@davispolk.com</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">October&nbsp;2, 2020</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Re:</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160; </font><b>Immunomedics,&nbsp;Inc.</b></p>
<p style="margin:0in 0in .0001pt .25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Schedule TO-T filed on September&nbsp;24, 2020</font></b></p>
<p style="margin:0in 0in .0001pt .25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Filed by Maui Merger Sub,&nbsp;Inc. and Gilead Sciences,&nbsp;Inc.</font></b></p>
<p style="margin:0in 0in .0001pt .25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">File No.&nbsp;005-35857</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Valian A. Afshar</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Special Counsel</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Office of Mergers and Acquisitions</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">United States Securities and Exchange Commission</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100 F Street, N.E.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Washington, D.C. 20549-3628</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dear Mr.&nbsp;Afshar:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This letter responds to comments of the Staff (the &#147;<b>Staff</b>&#148;) of the Securities and Exchange Commission (the&nbsp;&#147;<b>Commission</b>&#148;) contained in the letter from the Staff dated September&nbsp;30, 2020 (the &#147;<b>Comment Letter</b>&#148;) regarding the above-referenced Schedule TO-T of Gilead Sciences,&nbsp;Inc. (&#147;<b>Parent</b>&#148;) and Maui Merger Sub,&nbsp;Inc. (&#147;<b>Purchaser</b>&#148;) as filed with the Commission on September&nbsp;24, 2020 (the &#147;<b>Schedule TO</b>&#148;). In conjunction with this letter, Parent and Purchaser are filing via EDGAR, for review by the Staff, Amendment No.&nbsp;2 to the Schedule TO (&#147;<b>Amendment No.&nbsp;2</b>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please find enclosed three copies of Amendment No.&nbsp;2. The changes reflected in Amendment No.&nbsp;2 include those made in response to the comments of the Staff in the Comment Letter. </font>The responses set forth in this letter are numbered to correspond to the numbered comments in the Comment Letter. For your convenience, we have also included the text of the applicable comment in the Comment Letter in bold immediately before each response. All defined terms in this letter have the same meaning as ascribed to them in the Schedule TO, unless otherwise indicated.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;(a)(1)(A)&nbsp;&#151; Offer to Purchase</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Terms of the Offer, page&nbsp;11</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>We note the following statement on page&nbsp;13: &#147;Without Immunomedics&#146; consent, there will not be a subsequent offering period for the Offer.&#148; Please advise us how the conditional nature of this statement complies with Item 1004(a)(1)(iv)&nbsp;of Regulation M-A, or revise the statement accordingly.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In response to the Staff&#146;s comment, Parent and Purchaser have revised the fifteenth sentence of Section&nbsp;1 (&#147;Terms of the Offer&#148;) of the Offer to Purchase as follows: &#147;Purchaser will not provide for any subsequent offering period following the Expiration Date.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\C605352\20-30810-10\task9905240\30810-10-bc.htm',USER='C605352',CD='Oct  3 02:00 2020' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions of the Offer, page&nbsp;53</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>We note your statement on page&nbsp;55 that the Offer conditions &#147;may be asserted by Parent or Purchaser regardless of the circumstances giving rise to any such conditions (including any action or inaction by Parent or Purchaser).&#148; Conditions that are subjectively determinable or within the control of a bidder may result in the Offer being deemed illusory in contravention of Section&nbsp;14(e)&nbsp;of the Exchange Act. Please revise this statement to remove the implication that the Offer conditions may be triggered by your action or inaction.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In response to the Staff&#146;s comment, Parent and Purchaser have deleted &#147;(including any action or inaction by Parent or Purchaser)&#148; from the penultimate sentence of Section&nbsp;13 (&#147;Conditions of the Offer&#148;) of the Offer to Purchase.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>We note the following statement on page&nbsp;55: &#147;The failure by Parent or Purchaser at any time to exercise any of the foregoing rights will not be deemed a waiver of any such right and each such right will be deemed an ongoing right which may be asserted at any time and from time to time prior to the expiration of the Offer (except for conditions relating to government regulatory approvals).&#148; This statement suggests that you may become aware that an Offer condition has been triggered or otherwise has become incapable of being satisfied, yet the Offer may proceed without a disclosure being made. As stated elsewhere in the Offer to Purchase, however, the Offer materials must be amended to disclose material changes. To the extent you become aware of any condition being &#147;triggered&#148; that would enable you to terminate the Offer or otherwise cancel your obligation to accept tenders, and you elect to proceed with the Offer, we view that decision as being tantamount to a waiver of the condition and a material change to the Offer. Accordingly, please revise this disclosure to avoid any inconsistency with respect to your stated understanding of your planned treatment of material changes.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent and Purchaser respectfully acknowledge awareness of the Staff&#146;s position in this regard without necessarily agreeing with that position, and in response to the Staff&#146;s comment, Parent and Purchaser have revised the last sentence of Section&nbsp;13 (&#147;Conditions of the Offer&#148;) of the Offer to Purchase as follows: &#147;The failure by Parent or Purchaser at any time to exercise any of the foregoing rights will not be deemed a waiver of any such right and each such right will be deemed an ongoing right which may be asserted at any time and from time to time prior to the expiration of the Offer (except for conditions relating to government regulatory approvals)<u>, in each case subject to the terms of the Merger Agreement and the applicable rules&nbsp;and regulations of the SEC</u>.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;(a)(1)(B)&nbsp;&#151; Letter of Transmittal</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>We note the following statement: &#147;Purchaser&#146;s interpretation of the terms and conditions of the Offer (including the Letter of Transmittal and the instructions thereto) will be final and binding.&#148; Please revise this statement to remove the implication that stockholders may not challenge Purchaser&#146;s interpretations in a court of competent jurisdiction, consistent with the qualification contained in similar statements throughout the Letter of Transmittal and Offer to Purchase.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In response to the Staff&#146;s comment, Parent and Purchaser have revised the last sentence of the first paragraph on page&nbsp;11 of the Form of Letter of Transmittal as follows: &#147;Purchaser&#146;s interpretation of the terms and conditions of the Offer (including the Letter of Transmittal and the instructions thereto) will be final and binding<u>, subject to the rights of the tendering holders of Shares to challenge Purchaser&#146;s determination in a court of competent jurisdiction</u>.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_210158_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\C605352\20-30810-10\task9905240\30810-10-bc.htm',USER='C605352',CD='Oct  3 02:00 2020' -->

<div style="page-break-before:always;"></div>
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;(a)(1)(E)&nbsp;&#151; Letter to Clients for Use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Please revise the following statement in conformity with any revisions you make in response to comment #4 above: &#147;The undersigned understands and acknowledges that all questions as to validity, form and eligibility of the surrender of any certificate representing Shares submitted on my behalf will be determined by Purchaser and such determination shall be final and binding.&#148;</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In response to the Staff&#146;s comment, Parent and Purchaser have revised the second sentence of the second paragraph on page&nbsp;three of the Form of Letter to Clients for Use by Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees as follows: &#147;The undersigned understands and acknowledges that all questions as to validity, form and eligibility of the surrender of any certificate representing Shares submitted on my behalf will be determined by Purchaser and such determination shall be final and binding<u>, subject to the rights of the tendering holders of Shares to challenge Purchaser&#146;s determination in a court of competent jurisdiction</u>.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent and Purchaser acknowledge that (1)&nbsp;Parent and Purchaser are responsible for the adequacy and accuracy of the disclosure in their filings, (2)&nbsp;Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing and (3)&nbsp;neither Parent nor Purchaser may assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We are grateful for your assistance in this matter. Please do not hesitate to call me at (212) 450-</font>6145 with any questions you may have with respect to the foregoing.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very truly yours,</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Marc O. Williams</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Marc O. Williams,&nbsp;Esq.</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .3in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">cc:</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Brett A. Pletcher,&nbsp;Esq., Gilead Sciences,&nbsp;Inc.</p>
<p style="margin:0in 0in .0001pt .3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cheryl Chan,&nbsp;Esq., Davis Polk&nbsp;&amp; Wardwell LLP</font></p>
<p style="margin:0in 0in .0001pt .3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Adam O. Emmerich,&nbsp;Esq., Wachtell, Lipton, Rosen&nbsp;&amp; Katz</font></p>
<p style="margin:0in 0in .0001pt .3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Victor Goldfeld,&nbsp;Esq., Wachtell, Lipton, Rosen&nbsp;&amp; Katz</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="PB_3_210158_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\C605352\20-30810-10\task9905240\30810-10-bc.htm',USER='C605352',CD='Oct  3 02:00 2020' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g3081010bci001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g3081010bci001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  > )L# 2(  A$! Q$!_\0
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M5XY\2ZE-XJ&BV]^;"U0I&\@;;DL 2S$<X&:6[\-^*-"\B\T/6+C4PS?,J,6
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JZ[&N,TOX<PZ-KBZEI^I3Q;7)$6P%=AZH3Z5V=<U7E<KQ.JCSJ-I[G__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
